Literature DB >> 22654693

Changes in chronic low back pain and cardiovascular risk factors using a homeopathic human chorionic gonadotropin-based weight loss program: a case report.

Mark W Morningstar1, Megan N Strauchman.   

Abstract

OBJECTIVE: The purpose of this case report is to describe the changes in body weight and biochemical markers in a patient who completed a homeopathic human chorionic gonadotropin protocol. CASE REPORT: A 52-year-old man reported to an integrative medical center (including chiropractic and osteopathic physicians) for chronic low back pain. The patient reported a 20-year history of chronic, episodic low back pain. A course of spinal manipulative therapy was delivered; however, because of the lack of resolution of symptoms, a radiographic examination was performed, the result of which was essentially normal. Laboratory studies demonstrated hypercholesterolemia, hyperlipidemia, uricemia, and elevated blood glucose. A dietary change in treatment approach was selected. INTERVENTION AND OUTCOME: The patient was instructed to take 10 drops of a homeopathic human chorionic gonadotropin product under the tongue 5 times daily. His total daily energy (calorie) was limited for the first 30 days of the program while on the homeopathic product. After 4 months, the patient lost a total of 71 lb, pain and disability scores improved, and reductions in serum cardiovascular markers were noted.
CONCLUSION: The findings of this study showed that weight loss seemed to affect the patient's chronic low back pain and cardiovascular risk factors.

Entities:  

Keywords:  Gonadotropins; Low back pain; Materia medica; Weight loss

Year:  2011        PMID: 22654693      PMCID: PMC3315853          DOI: 10.1016/j.jcm.2011.08.005

Source DB:  PubMed          Journal:  J Chiropr Med        ISSN: 1556-3707


  12 in total

1.  The action of chorionic gonadotrophin in the obese.

Authors:  A T SIMEONS
Journal:  Lancet       Date:  1954-11-06       Impact factor: 79.321

2.  Obesity and sleep: a bidirectional association?

Authors:  Alexandros N Vgontzas; Edward O Bixler; Maria Basta
Journal:  Sleep       Date:  2010-05       Impact factor: 5.849

3.  Chorionic gonadotropin and obesity?

Authors:  M J Albrink
Journal:  Am J Clin Nutr       Date:  1969-06       Impact factor: 7.045

4.  Obesity and diabetes: two growing epidemics in California.

Authors:  Allison L Diamant; Susan H Babey; Joelle Wolstein; Malia Jones
Journal:  Policy Brief UCLA Cent Health Policy Res       Date:  2010-08

5.  Evaluation of metabolic syndrome in patients with chronic low back pain.

Authors:  Mehmet Tuncay Duruöz; Yasemin Turan; Alev Gürgan; Hülya Deveci
Journal:  Rheumatol Int       Date:  2010-12-05       Impact factor: 2.631

6.  Current depression among adults---United States, 2006 and 2008.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2010-10-01       Impact factor: 17.586

7.  Family physicians' barriers to cancer screening in extremely obese patients.

Authors:  Jeanne M Ferrante; Denise C Fyffe; Marielos L Vega; Alicja K Piasecki; Pamela A Ohman-Strickland; Benjamin F Crabtree
Journal:  Obesity (Silver Spring)       Date:  2009-12-17       Impact factor: 5.002

8.  Chorionic gonadotropin in weight control. A double-blind crossover study.

Authors:  R L Young; R J Fuchs; M J Woltjen
Journal:  JAMA       Date:  1976-11-29       Impact factor: 56.272

9.  Obesity-related cardiovascular risk factors after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention.

Authors:  D Hofsø; N Nordstrand; L K Johnson; T I Karlsen; H Hager; T Jenssen; J Bollerslev; K Godang; R Sandbu; J Røislien; J Hjelmesaeth
Journal:  Eur J Endocrinol       Date:  2010-08-26       Impact factor: 6.664

10.  Ineffectiveness of human chorionic gonadotropin in weight reduction: a double-blind study.

Authors:  M R Stein; R E Julis; C C Peck; W Hinshaw; J E Sawicki; J J Deller
Journal:  Am J Clin Nutr       Date:  1976-09       Impact factor: 7.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.